Evidence map›Paper›PMID 40936476›Full record

ArticleBritish journal of haematology2025

A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug-induced immune haemolytic anaemia.

Guillaume Brenac, Anne Dautriche, Romane Freppel, Anthony Facile, Bruno Revol, Mathilde Beurrier, Bernard Bonnotte, Sylvain Audia

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guillaume BrenacDepartment of Internal Medicine and Clinical Immunology, Constitutive Referral Centre for Adult Autoimmune Cytopenia, CHU Dijon-Bourgogne, Université Bourgogne Europe, Dijon, France.
Anne DautricheRegional Pharmacovigilance Center of Dijon, CHU Dijon-Bourgogne, Dijon, France.
Romane FreppelRegional Pharmacovigilance Center of Dijon, CHU Dijon-Bourgogne, Dijon, France.
Anthony FacileRegional Pharmacovigilance Center of Lyon, Hospices Civils de Lyon, Lyon, France.
Bruno RevolRegional Pharmacovigilance Center of Grenoble, CHU Grenoble-Alpes, Grenoble, France.ORCID https://orcid.org/0000-0003-2931-2940
Mathilde BeurrierRegional Pharmacovigilance Center of Nancy, CHU Nancy, Nancy, France.
Bernard BonnotteDepartment of Internal Medicine and Clinical Immunology, Constitutive Referral Centre for Adult Autoimmune Cytopenia, CHU Dijon-Bourgogne, Université Bourgogne Europe, Dijon, France.
Sylvain AudiaDepartment of Internal Medicine and Clinical Immunology, Constitutive Referral Centre for Adult Autoimmune Cytopenia, CHU Dijon-Bourgogne, Université Bourgogne Europe, Dijon, France.ORCID https://orcid.org/0000-0003-1772-1392

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoimmune haemolytic anaemiadrug adverse events

Identifiers

PMID40936476
PMCPMC12710132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.